Clinical Trial Update: Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating PF-04965842 for moderate to severe atopic dermatitis (eczema) in patients aged 12 and older; completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Dermatitis

Drugs mentioned

• PF-04965842

Snippet

Sponsor: Pfizer | Conditions: Dermatitis, Dermatitis, Atopic | Phase 3 | Status: COMPLETED | Results posted: 2021-09-20